About Biotheranostics
Biotheranostics is a company based in San Diego (United States) founded in 2008 was acquired by Hologic in January 2021.. Biotheranostics has raised $32 million across 1 funding round from investors including Hologic, MVM Partners and Canepa Healthcare. Biotheranostics operates in a competitive market with competitors including DermTech, Molbio Diagnostics, NeuMoDx, Kryptos Biotechnologies and PreludeDx, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biotheranostics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Biotheranostics
Biotheranostics has successfully raised a total of $32M through 1 strategic funding round. The most recent funding activity was a Series A round of $32 million completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $32.0M
-
First Round
First Round
(21 Jan 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2016 | Amount | Series A - Biotheranostics | Valuation | MVM |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biotheranostics
Biotheranostics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Hologic, MVM Partners and Canepa Healthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investments are focused on tech and life sciences startups.
|
Founded Year | Domain | Location | |
|
Private equity investments in healthcare companies are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biotheranostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biotheranostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biotheranostics Comparisons
Competitors of Biotheranostics
Biotheranostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, Molbio Diagnostics, NeuMoDx, Kryptos Biotechnologies and PreludeDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| domain | founded_year | HQ Location |
Risk assessment tests for early-stage breast cancer are provided.
|
|
| domain | founded_year | HQ Location |
Next-generation molecular detection kits for viral diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biotheranostics
Frequently Asked Questions about Biotheranostics
When was Biotheranostics founded?
Biotheranostics was founded in 2008 and raised its 1st funding round 8 years after it was founded.
Where is Biotheranostics located?
Biotheranostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Biotheranostics a funded company?
Biotheranostics is a funded company, having raised a total of $32M across 1 funding round to date. The company's 1st funding round was a Series A of $32M, raised on Jan 21, 2016.
What does Biotheranostics do?
BioTheranostics was founded in 2008 and is based in San Diego, United States. Operations focus on the biotechnology sector, where proprietary molecular-based diagnostic, prognostic, and predictive tests are developed and commercialized for cancer treatment guidance. Key offerings include the Breast Cancer Index for decisions on extended endocrine therapy in estrogen receptor-positive breast cancer, and Cancer Type ID for molecular diagnosis and biomarker analysis in metastatic cases.
Who are the top competitors of Biotheranostics?
Biotheranostics's top competitors include DermTech, Molbio Diagnostics and NeuMoDx.
Who are Biotheranostics's investors?
Biotheranostics has 4 investors. Key investors include Hologic, MVM Partners, Canepa Healthcare, and Health Quest Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.